drugset
Drugs / ESAT6-CFP10
last change Mar 2018 re-read 9 days ago

ESAT6-CFP10

also known as Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 · Recombinant Mycobacterium Tuberculosis Antigen ESAT6-CFP10

Protein / enzyme biologic

Investigated by
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Air Force Military Medical University, China · Proswell Medical Corporation · Shanghai Public Health Clinical Center · Tianjin Haihe Hospital · Wuhan Institute for Tuberculosis Control
+11 more · Anhui Provincial Hospital · Beijing Chest Hospital · Beijing Children's Hospital · First Affiliated Hospital of Chongqing Medical University · Fuzhou Pulmonary Hospital of Fujian · Jiangsu Province Centers for Disease Control and Prevention · Jurong Province Centers for Disease Control and Prevention · Shenzhen Third People's Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuxi Hospital for Infectious Diseases · Zhenjiang Third People's Hospital

Trials 6

today NCT03027154 · Ph 3 NCT02623556 · Ph 3 NCT02389322 · Ph 2 NCT02336542 · Ph 2 NCT02329730 · Ph 2 NCT01999231 · Ph 1
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01999231 Sep → Oct 2013 — Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Completed No outcome recorded
Phase 23 trials
Phase 2 NCT02389322 Mar → Jul 2015 tuberculosis Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Completed No outcome recorded
Phase 2 NCT02336542 Nov 2014 → Jul 2015 tuberculosis Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Completed No outcome recorded
Phase 2 NCT02329730 Feb → Jun 2014 tuberculosis Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Completed No outcome recorded
Phase 32 trials
Phase 3 NCT03027154 Oct 2016 → Oct 2017 tuberculosis Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Completed No outcome recorded
Phase 3 NCT02623556 Dec 2015 → Mar 2018 tuberculosis Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as ESAT6-CFP10 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03027154 ↗
5

NCT02329730 ↗

NCT01999231 ↗

NCT02336542 ↗

NCT02389322 ↗

NCT02623556 ↗
Known as Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 “For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase III Clinical Research” NCT02623556 ↗
Known as Recombinant Mycobacterium Tuberculosis Antigen ESAT6-CFP10 “Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Antigen ESAT6-CFP10” NCT02329730 ↗
Modality Protein / enzyme biologic “This trial was conducted to explore the safety of recombinant fusion protein ESAT6-CFP10 as a skin test reagent for the diagnosis of Mycobacterium tuberculosis infection.” PMID 27413070 ↗ Sep 2016
Route Other “inject intradermally with 5μg/ml ESAT6-CFP10” NCT02389322 ↗